Results 131 to 140 of about 25,871 (216)

A model for the clinical management of the introduction of new medicines in a large University Hospital in Spain. [PDF]

J Pharm Policy Pract
Danés I, Agustí A, Ballarín E, Marrero P, Vancells G, Clemente S, Vila M, Cortés S, Abadías MJ, Gorgas MQ, Diogène E.   +10 more
europepmc   +1 more source

Correction: C3a receptor signaling inhibits neurodegeneration induced by neonatal hypoxic-ischemic brain injury. [PDF]

Front Immunol
Pozo-Rodrigálvarez A, Li Y, Stokowska A, Wu J, Dehm V, Sourkova H, Steinbusch H, Mallard C, Hagberg H, Pekny M, Pekna M.   +10 more
europepmc   +1 more source

Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. [PDF]

JAMA Neurol
Vilaseca A, Bilodeau PA, Gakis G, Savransky A, Mahler Ferreira Oliveira J, Nguyen L, Hooshmand SI, Satyanarayan S, Moseley CE, Haley L, Roy-Hewitson C, Marrodan M, Casallas A, Manin A, Chen H, Hoshina Y, Grzezulkowska A, Carnero Contentti E, Galleguillos L, Upchurch M, Jackson-Tarlton CS, Chu-Yueh Guo J, Fabian M, Virupakshaiah A, Arrambide G, Caparó-Zamalloa C, Paterno R, Waubant E, Ordoñez Boschetti L, Correale J, Villa AM, Banwell B, Marignier R, Pittock SJ, Greenberg B, Bennett JL, Cho T, Clardy S, Solomon AJ, Kister I, Zamvil SS, Gelfand JM, Repovic P, Obeidat AZ, Blackburn K, Tenembaum S, Chen JJ, Sotirchos ES, Levy M, Flanagan EP, and The Americas MOGAD Treatment Group, Murillo F, Syc-Mazurzek SB, Cacciaguerra L, Jiang M, da Silva Rezende NB, Wingerchuk DM, Horsman SE.   +57 more
europepmc   +1 more source

Daratumumab Treatment in Severe Anti-NMDAR Encephalitis: Two Case Reports and Literature Review. [PDF]

Neurol Neuroimmunol Neuroinflamm
Ammar N, Uginet M, De Stefano P, Quintard H, Samii K, Seebach JD, Dalmau J, Lalive PH.   +7 more
europepmc   +1 more source

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results. [PDF]

Neurol Neuroimmunol Neuroinflamm
Vilaseca A, Filippatou AG, Said Y, Sechi E, Syc-Mazurek SB, Cacciaguerra L, Guo K, Vorasoot N, Niederschweiberer M, Thakolwiboon S, Sagen JA, Lopez-Chiriboga SA, Tillema JM, Chen JJ, Pittock SJ, Sotirchos ES, Flanagan EP.   +16 more
europepmc   +1 more source

Retinal Optical Coherence Tomography Longitudinal Measures as Prognostic Biomarkers in Multiple Sclerosis: Systematic Review and Meta-Analysis. [PDF]

Neurol Neuroimmunol Neuroinflamm
El Ayoubi NK, Ismail A, Sader G, Abi Chakra N, El Ahdab J, Abboud J, Khoury SJ.   +6 more
europepmc   +1 more source

Correction: Editorial: CNS immunity - paradox of maintenance, repair and destruction. [PDF]

Front Immunol
Ghosh A, Sankowski R, Acharya S, Bohmwald K.   +3 more
europepmc   +1 more source

Neuroinflammation and neuroimmunology in Alzheimer's disease: The role of T-lymphocytes in Alzheimer's disease

Alzheimer's disease (AD) is the leading cause of dementia, with the number of patients with AD expected to double in the next quarter-century. Brain deposition of amyloid-β (Aβ) and tau proteins is a necessary but insufficient condition for AD ...
Chihara, Norio, マツモト, リキ, 松本, 理器, 千原, 典夫, チハラ, ノリオ, Tsuji, Asato, Matsumoto, Riki   +6 more
core  

Neuroimmunology [PDF]

Journal of Neurochemistry, 2003
openaire   +2 more sources

Correction: Utility of Multi‑Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from Pseudoexacerbation. [PDF]

Neurol Ther
Okuda DT, Moog TM, McCreary MC, Huddleston IJ, Wright CM, Burgess KW, Santoyo JR, Sguigna PV, Stüve O, Tran DH.   +9 more
europepmc   +1 more source